Fact checked byGina Brockenbrough, MA

Read more

November 16, 2024
1 min read
Save

Corin receives FDA 510(k) clearance of Icona femoral stem

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Corin received FDA clearance of its Icona femoral stem for direct anterior total hip arthroplasty.
  • Icona is a collared, metaphyseal-filling, triple-taper femoral stem.

Corin has received FDA 510(k) clearance of its Icona femoral stem for direct anterior total hip arthroplasty with design considerations for use in the ASC setting, according to a press release.

The Icona femoral stem, which was designed using data from the CorinRegistry, is a collared, metaphyseal-filling, triple-taper stem for THA procedures, according to the release.

Generic FDA News infographic
Corin received FDA clearance of its Icona femoral stem for direct anterior THA.

“With design features tailored to the direct anterior approach and streamlined instrumentation for ASCs, Icona reflects the implementation of real-world data in innovation,” Cynthia Ansari, chief commercial officer at Corin USA, said in the release.

According to the release, Icona is available through a limited market release in the United States.